Skip to Main Content

Paper Details

Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.
Cancers
2
2021
EphB4, Ephrin Type-B Receptor 4 Tyrosine Kinase, PDAC, PDXs, Pancreatic Cancer, Pancreatic ductal adenocarcinoma, Patient, Patient-derived tumor xenografts, Tyrosine, anti-phosphotyrosine antibodies, cancers, ephrin type-B receptor 4, human, human serum albumin, mice, non-receptor tyrosine kinases, pancreatic cancer, pancreatic ductal adenocarcinoma, patients, phosphotyrosine, tissue, tumor, tyrosine, tyrosine kinases
Author NameAffiliation
Akhilesh PandeyMayo Clinic
Akhilesh PandeyCenter for Individualized Medicine, Mayo Clinic
Akhilesh PandeyManipal Academy of Higher Education (MAHE)
Akhilesh PandeyCenter for Molecular Medicine
  • 1 - 4

Datasets

Release 1.2